Cutaneous manifestations of hematologic malignancy represent both a clinical challenge for
the treating physician and a pathophysiological model for advancing the knowledge on …

Pyoderma gangrenosum (PG) is a rare, neutrophilic skin disease. For the purpose of
accurate diagnosis and proper treatment of PG, the Japanese clinical practice guidance for …

Pyoderma gangrenosum (PG) is a rare ulcerative skin disease that presents a therapeutic
challenge. Tumour necrosis factor alpha (TNFα) inhibitors have been reported to …

Pyoderma gangrenosum manifests as an ulceration of the skin often associated with several
systemic diseases. The diagnosis is usually made by exclusion criteria with suggestions …

Pyoderma gangrenosum is a rare, neutrophil‐mediated, auto‐inflammatory dermatosis that
wound care specialists must be prepared to recognise. This condition has clinical features …

Pyoderma gangrenosum (PG) is a rare disease of unknown aetiology, first described over a
century ago. Initially thought to have an infectious cause, and now primarily considered an …

Background Pyoderma gangrenosum (PG) is an uncommon but severe extra-intestinal
manifestation (EIM) of inflammatory bowel disease (IBD). The incidence and risk factors for …

Pyoderma gangrenosum is a challenging disease to manage, due in part to the lack of
approved treatment therapies. Recently, the emergence of biologic agents has expanded …

(1) Background: Pyoderma gangrenosum (PG) is a rare neutrophilic dermatosis of unknown
etiology. Coronavirus disease 2019 (COVID-19) vaccines can cause a variety of adverse …

Chronic wounds are a huge burden on the individual's quality of life (QoL) and healthcare
system (1-3). Right and early diagnostics of chronic wounds is essential for successful …